ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2017

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

R Lesurf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.